Economics,
on the record.
Twenty years of antitrust, class-certification, and damages analysis for federal and state matters. Reports that withstand Daubert. Testimony that withstands cross-examination.
Competition economics, antitrust damages, and class-certification analysis across pharmaceuticals, medical devices, financial services, energy, agriculture, and CPG — supported by econometric and statistical work designed to survive Daubert scrutiny.
Expert reports submitted to the U.S. District Court for the District of Columbia and the Eastern District of Virginia; deposition testimony in state and federal courts; white papers submitted to state departments of transportation and the FDA.
Where the work lives.
Antitrust & Competition
Market definition, monopoly power, price fixing, vertical restraints, and merger effects — on both sides of the v.
Class Certification
Econometric and statistical analysis addressing predominance, common impact, and classwide damages methodologies.
Economic Damages
Lost profits, overcharge, unjust enrichment, and Lanham Act damages — modeled to withstand Daubert.
Public Policy & Regulation
Economic-impact studies and white papers for regulatory proceedings, legislative initiatives, and trade associations.